BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28062087)

  • 1. Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial.
    Paelinck L; Gulyban A; Lakosi F; Vercauteren T; De Gersem W; Speleers B; Monten C; Mulliez T; Berkovic P; van Greveling A; Decoster F; Coucke P; De Neve W; Veldeman L
    Radiother Oncol; 2017 Jan; 122(1):30-36. PubMed ID: 28062087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions.
    Mulliez T; Veldeman L; van Greveling A; Speleers B; Sadeghi S; Berwouts D; Decoster F; Vercauteren T; De Gersem W; Van den Broecke R; De Neve W
    Radiother Oncol; 2013 Aug; 108(2):203-8. PubMed ID: 24044803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: Comparison with sequential boost in a randomized trial.
    Van Hulle H; Desaunois E; Vakaet V; Paelinck L; Schoepen M; Post G; Van Greveling A; Speleers B; Mareel M; De Neve W; Monten C; Deseyne P; Veldeman L
    Radiother Oncol; 2021 May; 158():62-66. PubMed ID: 33617910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.
    Hardee ME; Raza S; Becker SJ; Jozsef G; Lymberis SC; Hochman T; Goldberg JD; DeWyngaert KJ; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e415-23. PubMed ID: 22019349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.
    Swanick CW; Lei X; Shaitelman SF; Schlembach PJ; Bloom ES; Fingeret MC; Strom EA; Tereffe W; Woodward WA; Stauder MC; Dvorak T; Thompson AM; Buchholz TA; Smith BD
    Cancer; 2016 Sep; 122(18):2886-94. PubMed ID: 27305037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated whole breast irradiation with simultaneous integrated boost in breast cancer using helical tomotherapy with or without regional nodal irradiation: A report of acute toxicities.
    Chitapanarux I; Nobnop W; Onchan W; Klunklin P; Nanna T; Sitathanee C; Kulpisitthicharoen S; Sripan P
    Front Oncol; 2023; 13():1122093. PubMed ID: 37007149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
    Weng JK; Lei X; Schlembach P; Bloom ES; Shaitelman SF; Arzu IY; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):360-370. PubMed ID: 33992718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed.
    Cooper BT; Formenti-Ujlaki GF; Li X; Shin SM; Fenton-Kerimian M; Guth A; Roses DF; Hitchen CJ; Rosenstein BS; Dewyngaert JK; Goldberg JD; Formenti SC
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):571-8. PubMed ID: 27131077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance.
    Ott OJ; Strnad V; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Łyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Kortmann RD; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C;
    Radiother Oncol; 2016 Jul; 120(1):119-23. PubMed ID: 27422584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated whole breast irradiation with intensity-modulated radiotherapy to the prone breast.
    Croog VJ; Wu AJ; McCormick B; Beal KP
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):88-93. PubMed ID: 18676095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
    Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
    Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial.
    Vesprini D; Davidson M; Bosnic S; Truong P; Vallieres I; Fenkell L; Comsa D; El-Mallah M; Garcia L; Stevens C; Nakonechny K; Tran W; Kiss A; Rakovitch E; Pignol JP
    JAMA Oncol; 2022 Jul; 8(7):994-1000. PubMed ID: 35616948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.